2011-2012 Officers

• Catherine R. Lucey, MD, Chair
• Robert M. Wachter, MD, Chair-Elect
• Talmadge E. King Jr., MD, Secretary-Treasurer
• Christine K. Cassel, MD, President

2011 - 2012 Directors

• Charles S. Abrams, MD
• Lee R. Berkowitz, MD
• Shalendar Bhasin, MD
• Clarence H. Braddock III, MD
• William J. Bremner, MD
• Marie T. Brown, MD
• David L. Coleman, MD
• Patricia M. Conolly, MD
• David H. Ellison, MD
• Christopher E. Forsmark, MD
• John G. Harold, MD
• David P. Huston, MD
• David H. Johnson, MD
• George H. Karam, MD
• Harlan M. Krumholz, MD
• Sharon A. Levine, MD
• Stuart L. Linas, MD
• William C. Little, MD
• Naomi P. O'Grady, MD
• Olufunmilayo Olopade, MD
• Neil R. Powe, MD
• Richard P. Shannon, MD
• Christine A. Sinsky, MD
• Richard M. Stone, MD
• Joan M. Von Feldt, MD
• Keith R. Young MD

Catherine R. Lucey, MD, Chair

Dr. Lucey, a board certified internist and geriatrician, is currently interim Dean, College of Medicine, Vice Dean for Education at the Ohio State University (OSU) College of Medicine and Associate Vice President for Health Sciences Education for the OSU Office of Health Sciences. In September, she will become Vice Dean for Education at the University of California San Francisco School of Medicine. She has been a Director of the American Board of Internal Medicine since 2005 and is beginning her term as its Chair. She is also a member of the ABIM Foundation Board of Trustees.

Dr. Lucey was a Clinical Instructor at Harvard University School of Medicine, Assistant Professor of Medicine at the University of Texas, San Antonio, and Associate Professor of Medicine at the George Washington University School of Medicine and the Uniformed Services University of the Health Sciences, before joining Ohio State as Associate Professor of Medicine in 2002. She was promoted to Professor of Internal Medicine in 2005. She has won numerous teaching awards and has given more than 100 invited presentations at national meetings and academic institutions across the country. Her areas of expertise include professionalism and curriculum development.

A Fellow of the American College of Physicians, Dr. Lucey also is a prior council member for both the Society of General Internal Medicine and the Association of Program Directors in Internal Medicine.

Dr. Lucey earned her medical degree from the Northwestern University School of Medicine, and she completed her residency in internal medicine at San Francisco General Hospital, University of California, San Francisco.

Robert M. Wachter, MD

Dr. Wachter, a board certified internist, is Professor of Medicine at the University of California, San Francisco (UCSF), Associate Chairman of UCSF's Department of Medicine, Chief of the Medical Service at UCSF Medical Center, and Chief of UCSF's 50-faculty Division of Hospital Medicine. He serves on the Executive Committee of the American Board of Internal Medicine and is President-Elect of its Board of Directors.

Dr. Wachter is an expert in patient safety, health care quality and the organization of hospital care; he has published more than 250 articles and six books in these areas. He coined the term "hospitalist" in a 1996 New England Journal of Medicine article, and is generally acknowledged as the academic leader of the field, the fastest growing specialty in modern medical history. He is a past President of the Society of Hospital Medicine.

He is also a national leader in the fields of patient safety and health care quality. He is editor of AHRQ WebM&M, an online case-based patient safety journal, and AHRQ Patient Safety Network, the leading federal patient safety portal. Together, these websites receive 2 million visits each year. He has written two books on patient safety, and has discussed the topic on Good Morning America, PBS' NewsHour, CNN's American Morning, and CBS Sunday Morning. His blog, Wachter's World (www.wachtersworld.org) is one of the nation's most popular health care blogs. Modern Physician magazine has ranked him as one of the 30 most influential physicians in the U.S. several times; his #10 ranking in 2010 made him the most highly ranked academic physician in the country.

Talmadge E. King Jr., MD

Dr. King, who is board certified in both internal medicine and pulmonary medicine, is the Julius R. Krevans Distinguished Professor in Internal Medicine and Chair of the Department of Medicine at the University of California, San Francisco. He serves on the Executive Committee of the American Board of Internal Medicine and is Secretary-Treasurer of its Board of Directors.

Dr. King is a member of the Institute of Medicine of the National Academy of Sciences, the American Academy of Arts and Sciences, the Association of American Physicians, the American Clinical and Climatological Association and the Fleischner Society. He is a Master of the American College of Physicians and a Fellow of the American College of Chest Physicians. He serves on of the Advisory Council of the National Heart, Lung, and Blood Institute and the Board Directors of the National Committee for Quality Assurance. Dr. King served as President of the American Thoracic Society, and has served on the Lung Biology and Pathology Study Section of the National Institutes of Health (NIH), Pulmonary and Allergy Drugs Advisory Committee Center for Drug Evaluation and Research of the FDA and the NIH Advisory Board for Clinical Research.

He has been a member of several editorial boards including: American Journal of Respiratory and Critical Care Medicine, Annals of Internal Medicine, THORAX and Up-To-Date™ in Pulmonary and Critical Care Medicine. His research interest is the pathogenesis, diagnosis and management of inflammatory and immunologic lung injury. His bibliography comprises more than 300 publications. He has co-edited several books, including the acclaimed reference book Interstitial Lung Disease, now in its 5th edition; Murray and Nadel's Textbook of Respiratory Medicine (5th Ed.); and Medical Management of Vulnerable & Underserved Patients: Principles, Practice, Population, the only reference currently available that focuses on the treatment of patients living with chronic diseases in poor and minority populations.

Dr. King has been listed on several of the Best Doctors lists in America for more than a decade (including Best Doctors in America and America's Top Doctors). He received the Trudeau Medal from the ATS.

Christine K. Cassel, MD, President

Dr. Cassel, a leading expert in geriatric medicine, medical ethics and quality of care, is President and CEO of the American Board of Internal Medicine and the ABIM Foundation. She is board certified in internal medicine and geriatric medicine.

Dr. Cassel is past President of the American Federation for Aging Research and the American College of Physicians. She also formerly served as Dean of the School of Medicine and Vice President for Medical Affairs at Oregon Health & Science University, Chair of the Department of Geriatrics and Adult Development at Mount Sinai School of Medicine and Chief of General Internal Medicine at the University of Chicago.

Dr. Cassel is one of 20 scientists chosen by United States President Barack Obama to serve on the President’s Council of Advisors on Science and Technology (PCAST) and is co-Chair and physician leader of a PCAST report to the President on future directions of health information technology. A member of the Institute of Medicine (IOM) since 1992, she served on the IOM’s Comparative Effectiveness Research (CER) Committee and the IOM committees that wrote the influential reports, “To Err is Human” and “Crossing the Quality Chasm.” She chaired major IOM reports on public health (2002) and on palliative care (1997). In 2009 and 2010, Modern Healthcare named Dr. Cassel among the 50 most powerful people in health care. An active scholar and lecturer, she is the author or co-author of 14 books and more than 200 journal articles on geriatric medicine, aging, bioethics and health policy.

A graduate of the University of Chicago, Dr. Cassel received her medical degree from the University of Massachusetts Medical School. She is the recipient of numerous honorary degrees and awards of distinction, including honorary Fellowship in the Royal College of Medicine of England and the Royal College of Physicians and Surgeons of Canada, as well as Mastership in the American College of Physicians.

Charles S. Abrams, MD

Dr. Abrams, who is board certified in internal medicine, hematology and oncology, is Associate Chief of Hematology-Oncology at the University of Pennsylvania School of Medicine.

Dr. Abrams is a sought-after lecturer on topics related to hematology/oncology. His recent publications have appeared in Blood, the Proceedings of the National Academy of Science and Science.

He is the Secretary of American Society of Hematology, and serves on their Executive Committee. Dr. Abrams has been elected to the American Society for Clinical Investigation and the Association of American Physicians. He is the Chair of the Hemostasis-Thrombosis Study Section of the National Institutes of Health Center for Scientific Review, and has formerly chaired the Thrombosis Study Section of the National American Heart Association. Dr. Abrams is also Chair of ABIM's Subspecialty Board on Hematology.

He earned his medical degree from Yale University School of Medicine.

Lee R. Berkowitz, MD

Dr. Berkowitz, a board certified internist and hematologist, is the Eunice Bernhard Distinguished Professor and Associate Chair of Education in the Division of General Internal Medicine at the University of North Carolina (UNC) at Chapel Hill. His academic career has centered on his role as Residency Program Director at UNC.

Currently, Dr. Berkowitz serves as a member of the ABIM Internal Medicine Exam-Writing Committee and as Chair of the Alliance for Academic Medicine's Task Force on Education Redesign of Graduate Medical Education. He has served as President of the Association of Program Directors in Internal Medicine and as Chair of the In-Training Examination Test Writing Committee of the American College of Physicians.

Dr. Berkowitz earned his medical degree at the Ohio State University College of Medicine. He did his residency and chief residency in the Department of Medicine at the University of North Carolina at Chapel Hill and later completed fellowship training in hematology at Washington University and UNC.

Shalendar Bhasin, MD

Shalender Bhasin, a board certified internist and endocrinologist, is Professor of Medicine at Boston University School of Medicine, and Chief of the Section of Endocrinology, Diabetes, and Nutrition at Boston Medical Center in Boston, Massachusetts.

Dr. Bhasin is an internationally recognized endocrinologist and serves as Chair of the Endocrine Society’s Clinical Guidelines Subcommittee. He is an Associate Editor for the Journal of Clinical Endocrinology and Metabolism, and is director of The Boston Claude D. Pepper Older Americans Independence Center for Function Promoting Therapies. He is a former Chair of Endocrine Society’s Expert Panel for the development of Guidelines for Testosterone Therapy. A member of the American Board of Internal Medicine's Board of Directors, Dr. Bhasin is Chair of the ABIM Subspecialty Board on Endocrinology, Diabetes, and Metabolism.

His laboratory provided the first unequivocal evidence of the anabolic effects of androgens in humans, demonstrated that androgens regulate differentiation of mesenchymal stem cells, and invoked the activation of Wnt target genes through beta-catenin-TCF-4 pathway. He is a translational researcher, supported by several National Institutes of Health-funded grants for more than 20 years, and has been the recipient of numerous teaching and research awards.

Dr. Bhasin obtained his medical education at the All India Institute of Medical Sciences in New Delhi, India. He received his residency training at Northwestern University Medical School and fellowship training in Endocrinology and Nutrition at Harbor-UCLA Medical Center in Los Angeles, California.

Clarence H. Braddock, III, MD

Dr. Braddock, a board certified internist, is Professor of Medicine at Stanford University School of Medicine, where he is Associate Dean for Undergraduate and Graduate Medical Education and Director of the Standford Center for Medical Education Research and Innovation. He is also Director of Clinical Ethics at the Stanford Center for Biomedical Ethics. A member of the American Board of Internal Medicine (ABIM)’s Board of Directors, he also is Chair of ABIM’s Practice Improvement Modules Oversight Committee.

Dr. Braddock has been a national leader in medical education, particularly in bioethics. He launched the Bioethics Education Project at University of Washington, an initiative that expanded ethics and professionalism education, and the Practice of Medicine program at Stanford, an initiative that integrated ethics, professionalism, doctor-patient communication and population health into the pre-clerkship medical school curriculum. His research has focused on shared decision-making and patient-physician communication, having lead to development of a widely used model for teaching and for evaluation of practice.

Dr. Braddock currently serves on the Ethics, Professionalism and Human Rights Committee for the American College of Physicians and the Ethics Committee for the Society of General Internal Medicine. He is Director of the National Consortium for Multicultural Education for Health Professionals.

After earning his undergraduate degree at Stanford University and medical degree at the University of Chicago, Dr. Braddock completed residency training in the U.S. Navy and received his master’s in public health degree in health care ethics from the University of Washington.

William J. Bremner, MD

Dr. Bremner, a board certified internist, is the Robert G. Petersdorf Professor and Chair of the Department of Medicine at the University of Washington School of Medicine. He is co-Founder and Director of the Center for Research in Reproduction and Contraception at the University of Washington. Funded continuously by the NIH since 1979, the Center investigates the basic biology of male reproduction, infertility and contraception. Dr. Bremner is also an active physician and teacher at University of Washington Medical Center in Seattle.

He is the author or co-author of more than 200 scientific publications and more than 50 book chapters and has held more than 100 invited lectureships and visiting professorships around the world over the past 25 years. He is a member of Alpha Omega Alpha Medical Honorary and a recipient of the Henry Christian Award for Excellence in Research from the American Federation for Clinical Research. In 2003 he received the University of Washington School of Medicine Distinguished Alumni Award, and in 2005 he was given the Mayo Soley Award by the Western Society for Clinical Investigation in recognition of lifetime achievement in scientific endeavors and for his concern for junior faculty. He has been elected to the scientific and honorary societies: American Society for Clinical Investigation and the Associations of American Physicians.

He is a past-President of the Association of Professors of Medicine (APM) and the American Society of Andrology. He has served on numerous national and international bodies, including NIH review groups, the Steering Committee for the World Health Organization Special Program on Research in Human Reproduction and the Expert Advisory Committee, Agency for International Development/CONRAD Program, and the U.S. Department of Veterans Affairs Blue Ribbon Panel on Academic Affiliations.

Marie T. Brown, MD

Dr. Brown is an Assistant Professor of Medicine, Department of Internal Medicine, Rush University Medical Center Chicago, Illinois. She is a practicing, board certified internist and geriatrician.

Dr. Brown serves as a Director for the American Board of Internal Medicine and is Chair of the ABIM Internal Medicine Exam-Writing Committee. She is Governor-elect of the Northern Illinois Chapter of the American College of Physicians on staff at Rush University Medical Center and MacNeal Hospital. She currently serves on the Board of Directors of the Council of Medical Specialty Societies as Treasurer. In addition to her clinical work, Dr. Brown has participated in clinical research regarding hypertension in the LIFE study and lectures and consults regarding a variety of internal medicine topics including stroke, hypertension, PAD, diabetes, Alzheimer’s disease and other age-related issues.

Her publications include reviews in the Mayo Clinic Proceedings and the American Journal of Medicine. She served on the Board of Directors for the Iowa Foundation for Medical Care and on the Board of Managers for the Illinois Foundation for Quality Health Care, the statewide quality improvement organizations for Illinois and Iowa. Dr. Brown was a member of the American College of Physicians Scientific Program Committee for 2005 and Chair of the Scientific Program Subcommittee for the American College of Physicians Annual Session 2007, and served on the national ACP Medical Education Committee. She has been active in guideline development for cardiovascular disease, specifically congestive heart failure. Since 2003, she has served as a member of the U.S. Coordinating Committee for the Worldwide REACH Registry.

After earning her medical degree from Rush Medical College in Chicago, she completed an internship and residency in internal medicine at Rush-Presbyterian-St. Luke’s Hospital. She became a Fellow of the American College of Physicians in 1993.

David L. Coleman, MD

Dr. Coleman, a board certified internist and infectious disease specialist, is the John Wade Professor & Chair of the Department of Medicine at the Boston University School of Medicine. He has a long-standing interest in basic mechanisms of macrophage function and the role of cytokines in regulating host defenses. His work focuses on medical and civic professionalism in medical education and clinical practice.

Prior to assuming his current position, Dr. Coleman was Chief of Medical Service at the VA Connecticut Healthcare System and Interim Chair of the Department of Medicine at Yale University School of Medicine.

He serves on the Board of Trustees of the Boston Medical Center, on the Board of Directors of the Faculty Practice Plan of Boston Medical Center and Boston University School of Medicine, and is a member of the Executive Committee at Boston University School of Medicine. Dr. Coleman is a Fellow of the American College of Physicians. He is also a member of the Association of Professors of Medicine (APM) Clinical Care Committee and serves on the Editorial Board of Infection. A member of the American Board of Internal Medicine's Board of Directors, he is also a member of the ABIM Internal Medicine Exam-Writing Committee.

A graduate of Stanford University, Dr. Coleman completed his medical degree at the University of California, San Francisco. He did his residency and fellowship in the Department of Internal Medicine at Yale University, where he also served as Chief Resident.

Patricia M. Conolly, MD

Dr. Conolly, a board certified internist, is Associate Executive Director of The Permanente Medical Group where she has oversight of multiple services that impact greater than three million members of Kaiser Permanente in Northern California. Her current work includes the development and use of technology in health care delivery with three key areas of emphasis: leveraging the electronic medical record to improve quality, developing applications to engage patients in understanding and managing their health and extending the reach of the delivery system to patients where and when they need care. Of particular interest is the development of Web-based applications to support informed decision-making.

Dr. Conolly currently practices at Kaiser Permanente's Oakland Medical Center where she was Chief of Medicine and Director of their internal medicine residency program as well as Director of Medical Education. She chaired Kaiser Permanente’s Northern California Pharmacy and Therapeutics Committee, overseeing evidence-based clinical guidelines for medication use as well as the formulary process. A member of the American Board of Internal Medicine's Board of Directors, she also serves on the ABIM Internal Medicine Exam-Writing Committee.

Dr. Conolly earned her medical degree from the University of California, Los Angeles, and served on the clinical faculty at the University of California, San Francisco School of Medicine. She continues as a clinical preceptor in the UC Berkeley/UC San Francisco Joint Medical Program. She is a fellow of the American College of Physicians.

David H. Ellison, MD

Dr. Ellison, a board certified internist and nephrologist, is Professor of Medicine and Physiology and Pharmacology and Head of the Division of Nephrology and Hypertension at Oregon Health & Science University. He is also a staff physician at the Portland VA Medical Center, a practicing nephrologist with an active clinical practice and a dedicated teacher and mentor to medical students, residents, nephrology fellows and post-doctoral scientists.

A member of the American Board of Internal Medicine's Board of Directors, Dr. Ellison serves on the ABIM Subspecialty Board on Nephrology. He is Head President Council on the Kidney in Cardiovascular Disease for the American Heart Association, and was the 2010 Program Committee Chair for the American Society of Nephrology.

Dr. Ellison's research centers on the genetic basis of human blood pressure variation and on diuretic treatment of heart failure and hypertension. He has a long-standing interest in how salt is reabsorbed by the kidney. His special interest is a protein that is target of thiazide diuretics, drugs that are recommended as first line antihypertensive agents by the Joint National Committee on Detection and Treatment of Hypertension. His laboratory has recently discovered how a new class of protein kinases regulates the salt transport gene in the kidney. Recent work from the laboratory has elucidated how mutations in these kinases can cause a form of inherited human hypertension. This work is expected to lead to the development of new types of drugs to treat hypertension, the most common disease in the United States and in Western countries. It is also hoped to elucidate the pathogenesis of essential hypertension, paving the way for more effective prevention strategies.

Christopher E. Forsmark, MD

Dr. Forsmark, who is board certified in internal medicine and gastroenterology, is Professor of Medicine and the Chief of the Division of Gastroenterology, Hepatology and Nutrition at the University of Florida (UF). He also serves as the Training Program Director for the UF Gastroenterology Fellowship program.

His clinical and research interests are in the areas of acute and chronic pancreatitis, pancreatic function and function testing, biliary and pancreatic malignancy, and advanced therapeutic endoscopy. He is the former President of the American Pancreatic Association and the author of many book chapters, reviews and editorials, and original research in these areas of focus. A member of the American Board of Internal Medicine's Board of Directors, Dr. Forsmark is also Chair of the ABIM Subspecialty Board on Gastroenterology.

John G. Harold, MD

Dr. Harold, who is board certified in internal medicine, cardiovascular disease, geriatric medicine and critical care medicine, is a past Chief of Staff at Cedars-Sinai Medical Center in Los Angeles. He is Clinical Professor of Medicine in the David Geffen School of Medicine at the University of California at Los Angeles (UCLA) and is an attending physician at the Cedars-Sinai Heart Institute. He serves on the Executive Committee of the American Board of Internal Medicine’s Board of Directors.

Dr. Harold is the Vice President of the American College of Cardiology, past Chair of its Board of Governors, and ACC Secretary. He is a member of the Board of Directors of numerous organizations, including the Los Angeles Affiliate of the American Heart Association, Save A Heart Foundation, the Heart Fund at Cedars-Sinai and the UCLA Clinical Faculty Association.

He completed his internal medicine training at the Mount Sinai Hospital in New York and completed a fellowship in cardiology at Cedars-Sinai Medical Center in Los Angeles. He was honored with the Master designation from both the American College of Physicians and the American College of Cardiology.

David P. Huston, MD

Dr. Huston is Vice Dean for Texas A&M University Health Science Center College of Medicine, Professor of Medicine and of Microbial and Molecular Pathogenesis, and Director for the Texas A&M Clinical and Translational Research Institute. He is board certified in allergy and immunology, diagnostic and laboratory immunology, rheumatology and internal medicine.

He was on the faculty at Baylor College of Medicine for 28 years, where he was Professor of Medicine and Immunology, Cullen Chair in Immunology, Director of the Biology of Inflammation Center and Co-Director of the HHMI Translational Biology and Molecular Medicine program in the Graduate School of Biological Sciences.

His research interests focus on mechanisms of allergic inflammation. He is an NIH-funded investigator with more than 100 publications and several patents, and has served on NIH study sections for over 20 years. Consistently listed among the Best Doctors in America, Dr. Huston has held a number of national leadership positions in the American Academy of Allergy Asthma and Immunology and the Clinical Immunology Society, and has served on several editorial boards and as a consultant with NASA for human research on the international space station.

Dr. Huston currently serves on the Board of Directors for the American Board of Allergy and Immunology, the American Board of Internal Medicine and the American Academy of Allergy, Asthma and Immunology; and as a member of the ACGME Residency Review Committee for Allergy and Immunology. In addition, he has been elected to the American Clinical and Climatological Association and to the Association of American Physicians.

He received his undergraduate degree from Wofford College and his medical degree from Wake Forest University. He trained in internal medicine at Baylor College of Medicine and completed fellowship training in rheumatology and in allergy and immunology at the NIH.

David H. Johnson, MD

Dr. Johnson, who is board certified in internal medicine and medical oncology, is the Donald W. Seldin Distinguished Chair in Internal Medicine and Chairman of the Department of Internal Medicine at UT Southwestern Medical Center in Dallas, Texas. He is a member of the American Board of Internal Medicine's Board of Directors and previously served as the Chair of the ABIM Subspecialty Board for Medical Oncology.

From 1983 to 2010, Dr. Johnson was a member of the faculty at the Vanderbilt University Medical School where he held the Cornelius A. Craig Chair of Medical and Surgical Oncology and served as the Director of the Division of Hematology and Medical Oncology and Deputy Director of the Vanderbilt-Ingram Cancer Center, of which he was a founding member.

In 2004-2005, Dr. Johnson served as President of the American Society of Clinical Oncology (ASCO) during which time he helped advance ASCO's quality of care activity known as the Quality Oncology Practice Initiative (or QOPI®). QOPI was subsequently adopted as a Practice Improvement Module for diplomates seeking to maintain their certification in medical oncology. He was instrumental in establishing ASCO's Cancer Survivorship Program. Dr. Johnson also has served on the Food and Drug Administration’s Oncology Drug Advisory Committee, as Chairman of the Thoracic Committee of the Eastern Cooperative Oncology Group and on the Board of Directors of the National Comprehensive Cancer Network, the International Association for the Study of Lung Cancer (IASLC) and the LiveSTRONG Foundation. He has authored more than 330 peer reviewed articles and 40 book chapters and edited four oncology textbooks.

Dr. Johnson earned his medical degree from the Medical College of Georgia and obtained his medical oncology training at Vanderbilt University.

George H. Karam, MD

Dr. Karam, a board certified internist and infectious disease specialist, is the Paula Garvey Manship Professor of Medicine at the Louisiana State University School of Medicine.

He is a member of many professional associations including the Association of Professors of Medicine, Association of Program Directors in Internal Medicine and Infectious Disease Society of America. A member of the American Board of Internal Medicine's Board of Directors, he is also Chair of the ABIM Subspecialty Board on Infectious Disease. His work has been published extensively in leading professional journals, including Journal of Infectious Diseases, The New England Journal of Medicine and Annals of Internal Medicine.

Dr. Karam received his medical degree from the Louisiana State University School of Medicine. He serves as Chair of the American Board of Internal Medicine’s Subspecialty Board on Infectious Disease.

Harlan M. Krumholz, MD

Dr. Krumholz, a board certified internist and cardiovascular disease specialist, is the Harold H. Hines, Jr. Professor of Medicine and Epidemiology and Public Health at Yale University School of Medicine, where he is Director of the Robert Wood Johnson Clinical Scholars Program. He is also the Director of the Yale-New Haven Hospital Center for Outcomes Research and Evaluation.

His research is focused on determining optimal clinical and population-based strategies for improving the prevention, treatment and outcome of cardiovascular disease. The research and its application has contributed to elevating the quality of practice, eliminating disparities, defining new treatment standards, improving professional standards and guiding health care policy.

Dr. Krumholz is an elected member of the Association of American Physicians, the American Society for Clinical Investigation and the Institute of Medicine. He was named an American Heart Association Distinguished Scientist.

Dr. Krumholz earned his medical degree from Harvard Medical School and a master's degree in health policy and management at the Harvard School of Public Health. He trained in internal medicine at the University of California, San Francisco and in cardiology at Beth Israel in Boston.

Sharon A. Levine, MD

Dr. Levine, board certified in internal medicine and geriatric medicine, is Professor of Medicine and Associate Dean of Academic Affairs at the Boston University School of Medicine.

Previously, she taught medicine at Yale-New Haven Hospital.

Dr. Levine is the winner of the prestigious Metcalf Cup, Boston University’s highest teaching award as well as the Department of Medicine’s Robert Dawson Evans Special Recognition Teaching Award. She has served on numerous national education committees and, through her commitment to mentoring, has supported and inspired trainees at all levels, including numerous Geriatric Academic Career Award recipients. In 2004 she received one of three mentorship awards conferred by the Society of General Internal Medicine. Dr. Levine has authored numerous peer-reviewed publications which focused on the dissemination of innovative teaching models.

Among her many significant contributions to geriatrics education, Dr. Levine created Boston University’s Chief Resident Immersion Training (CRIT) in the Care of Older Adults program through the support of the Donald W. Reynolds Foundation. The program focuses on providing chief residents with a combination of training focused on improving their understanding of geriatrics principles and their leadership and teaching skills. Now in its seventh year, the program has been offered at 15 other institutions nationwide, through a national demonstration project supported by the John A. Hartford Foundation of New York. A member of the American Board of Internal Medicine's Board of Directors, Dr. Levine is Chair of the ABIM Subspecialty Board on Geriatric Medicine.

Dr. Levine received her medical degree from Albert Einstein College of Medicine and completed her residency in internal medicine at Yale-New Haven Hospital.

Stuart L. Linas, MD

Dr. Linas, a board certified internist and nephrologist, is the Rocky Mountain Professor of Renal Research at the University of Colorado Denver School of Medicine (UCDSOM). He has served on the faculty at the University of Colorado throughout his academic career and has been the Renal Fellowship Director since 1984 and the Head of the Section of Hypertension within the Division of Renal Diseases since 1994. Dr. Linas is the Chief of Nephrology at Denver Health Medical Center.

He has won numerous teaching awards from medical students and house staff at the University of Colorado. He currently co-chairs the Curriculum Steering Committee at the UCDSOM. Dr. Linas is on the Board of Advisors and has served as the Chair of the Renal Fellowship Program Directors for the American Society of Nephrology. He has served as the President of the Association of Specialty Professors and on the Board of Directors of the Alliance of Academic Internal Medicine. He is a past Chair of the ABIM Subspecialty Board on Nephrology.

After earning a medical degree from Tufts University School of Medicine, he completed internal medicine residency at the University of Rochester School of Medicine and nephrology training at the University of Colorado.

William C. Little, MD

Dr. Little, who is board certified in internal medicine, cardiovascular disease and interventional cardiology, is Chief of Cardiology, McMichael Professor and Vice-Chair of the Department of Internal Medicine at the Wake Forest University School of Medicine in Winston-Salem, North Carolina.

He is a Fellow of the American Heart Association (Council on Clinical Cardiology) and the American College of Cardiology; a member of the American Society of Clinical Investigation, American Association of Physicians, Association of University Cardiologists, and the Association of Professors of Cardiology (President in 2005). He is also the 2010 recipient of the American Heart Association’s Laennec Master Clinician Award, and the American Physiological Society’s Lamport Award for Cardiac Research, and has served as the Chair of the NIH Cardiovascular Study Section and VA Cardiovascular Merit Review Board. A member of the American Board of Internal Medicine's Board of Directors, Dr. Little is also Chair of the ABIM Subspecialty Board on Cardiovascular Disease. He is also a respected and frequently-cited author, having published more than 225 peer-reviewed articles.

His key research accomplishments include: finding that myocardial infarction most commonly results from the sudden occlusion of a coronary artery that did not previously contain an obstructive stenosis; demonstrating the role of left ventricular (LV) diastolic dysfunction in the pathogenesis of acute pulmonary edema; the pathophysiologic characterization of heart failure with a preserved ejection fraction; the physiologic mechanisms of normal and abnormal LV filling at rest and during exercise; the importance of angiotensin II and endothelin in diastolic dysfunction; and the first detailed evaluation of the effect of dyssynchronous electrical activation on LV performance. Other contributions include methods of assessing LV systolic and diastolic performance and LV arterial coupling and the clinical characterization of Chagas’ disease. His current research activities include the evaluation of LV diastolic function using advanced imaging techniques and therapy for patients with heart failure and a preserved ejection fraction.

Naomi P. O'Grady, MD

Dr. O’Grady, who is board certified in infectious disease and critical care medicine, is a senior staff physician in the National Institutes of Health (NIH) Clinical Center’s Critical Care Medicine Department and the Medical Director of the Clinical Center’s Vascular Access and Conscious Sedation Services. She also is an attending physician with the Pediatric Critical Care Medicine Department of the Children’s National Medical Center and an Assistant Professor in the Department of Internal Medicine’s Division of Infectious Diseases at Johns Hopkins University School of Medicine.

A member of the American Board of Internal Medicine's Board of Directors, Dr. O'Grady is also Chair of the ABIM Subspecialty Board on Critical Care Medicine. Her research interests include strategies to reduce the incidence of antimicrobial resistant pathogens in the ICU, and catheter-related blood stream infections. She is also actively involved in guideline development and implementation, having chaired the Infectious Diseases Society’s Guidelines Committee for three years. In addition, she has authored several guidelines related to fever in the ICU and catheter-related bloodstream infections.

A graduate of the University of Michigan, Dr. O’Grady earned her medical degree at Ohio State University, and completed fellowships with NIH and Johns Hopkins University. She is a Fellow of the American College of Critical Care Medicine and of the Infectious Diseases Society of America.

Olufunmilayo I. Olopade, MD

Dr. Olopade, who is board certified in internal medicine, medical oncology and hematology, is the Walter L. Palmer Distinguished Service Professor of Medicine and Associate Dean of Global Health at the University of Chicago. Her research focuses on the genetic causes of breast cancer, and she was instrumental in creating the Center for Clinical Cancer Genetics at the University of Chicago. Dr. Olopade is Program Director of Fellowship Training for the Section of Hematology/Oncology and a professor in that department and the Department of Human Genetics at the University of Chicago's Pritzker School of Medicine. She is also a practicing clinician and Director of the University's Cancer Risk Clinic.

Dr. Olopade is a leader in numerous professional organizations and has served as Chair of the American Society of Clinical Oncology Cancer Genetics Education Task Force. She is a frequent lecturer in the U.S. and abroad and has been honored numerous times for her contributions to medicine, perhaps most notably with a MacArthur Fellowship Genius Award and an honorary degree from Princeton University.

Dr. Olopade studied medicine in her native Nigeria, where she earned an MBBS (or Bachelor of Medicine and Surgery) with distinctions in Pathology and Pediatrics from the University of Ibadan, Nigeria. After completing an internship in medicine, surgery, pediatrics and OB/GYN at the University College Hospital in Ibadan, Nigeria and serving as a medical officer at the Nigerian Navy Hospital in Lagos, Nigeria, Dr. Olopade completed her residency and chief residency at Cook County Hospital in Chicago. Following, she completed a post-doctoral fellowship in both hematology and oncology at the University of Chicago.

Neil R. Powe, MD

Dr. Powe, who is board certified in internal medicine, is Chief of the Medicine Service at San Francisco General Hospital and Constance B. Wofsy Distinguished Professor and Vice-Chair of Medicine at the University of California, San Francisco. He is a member of the American Board of Internal Medicine’s Board of Directors.

Prior to his role at UCSF, Dr. Powe served as the James Fries University Distinguished Service Professor of Medicine and Director of the Welch Center at Johns Hopkins.

He has extensive experience in developing and measuring outcomes in chronic kidney disease. His research has involved clinical epidemiology, health services research and patient outcomes research using prospective methods of randomized controlled trials and cohort studies, cost-effectiveness analysis, meta-analysis, retrospective analyses of administrative databases and survey research. He has studied early referral of chronic kidney disease patients, patient-physician contact in dialysis care, cost-effectiveness of screening for proteinuria, racial differences in cardiovascular procedure use among CKD patients, effect of treatment modalities on survival, outcomes of dialysis care by type of ownership, access to transplantation and organ donation.

Dr. Powe is a member of the Institute of Medicine, the American Society of Clinical Investigation, the Association of American Physicians, the American Society of Epidemiology and a Master of the American College of Physicians. He is past Chair of the National Advisory Committee for Healthcare Research and Quality.

Dr. Powe earned his medical degree at Harvard Medical School and his master's in public health at Harvard School of Public Health. He completed residency, was a Robert Wood Johnson Clinical Scholar and completed his master's in business administration at the University of Pennsylvania.

Richard P. Shannon, MD

Dr. Shannon, a board certified internist and cardiovascular disease specialist and a pioneer in patient safety, is the Frank Wister Thomas Professor of Medicine at the University of Pennsylvania School of Medicine. He currently serves as Chair of the Department of Medicine of the University of Pennsylvania Health System.

Before joining the University of Pennsylvania in 2006, Dr. Shannon served as the Claude R. Joyner Professor of Medicine at Drexel University College of Medicine. Prior to that, he spent 14 years at Harvard Medical School, serving in a variety of capacities: Research Fellow, Instructor of Medicine, Assistant Professor of Medicine and finally Associate Professor of Medicine, and The Francis Weld Peabody Fellow in Medicine.

His work in patient safety has been featured in the Wall Street Journal and ABC's 20/20, and he has served as a mentor for the IHI 100,000 Lives campaign. His work on patient safety was a centerpiece for the PBS feature entitled "Remaking American Medicine." Dr. Shannon is a member of the (PA) Governor's Technical Advisory Group of the Pennsylvania Healthcare Cost Containment Council. He has served as a consultant to the Delmarva Foundation, The Safest in America Consortium, Blue Cross/Blue Shield of Massachusetts, the New York City Business Group on Health and the U.S. House of Representatives Committee on Energy and Commerce.

Dr. Shannon graduated cum laude from Princeton University, where he earned a bachelor's degree in biology. He earned his medical degree from the University of Connecticut School of Medicine.

Christine A. Sinsky, MD

Dr. Sinsky, a board certified internist, practices internal medicine at Medical Associates Clinic and Health Plans in Dubuque, Iowa.

She serves on the physician advisory panel for the National Committee for Quality Assurance (NCQA) physician recognition programs, is a member of the Society of General Internal Medicine’s Patient Centered Medical Home (PCMH) working group and is a consultant for the John D. Stoeckle Center for Primary Care Innovation at the Massachusetts General Hospital. Her practice has been a level 3 Patient Centered Medical Home since 2008. She is also a member of the American Board of Internal Medicine's Board of Directors and the Institute of Medicine’s Committee on Patient Safety and Health Information Technology.

Dr. Sinsky is a frequent speaker on practice innovation, redesign, and the Patient-Centered Medical Home, including for the American College of Physicians, the Institute for Healthcare Improvement, the Patient Centered Primary Care Collaborative as well as private and academic medical centers.

Dr. Sinsky received her bachelors and medical degrees from the University of Wisconsin and completed her post-graduate residency at Gundersen Medical Foundation/La Crosse Lutheran Hospital, in LaCrosse, Wisconsin, where she served as Chief Medical Resident.

Richard M. Stone, MD

Dr. Stone, who is board certified in internal medicine, medical oncology and hematology, is the Director of the Adult Acute Leukemia Program at Dana-Farber Cancer Institute, and Professor of Medicine at Harvard Medical School. A physician-scientist, he is nationally recognized for his laboratory and clinical research concerning blood and bone marrow malignancies including acute leukemia, myeloproliferative disorders and myelodysplastic syndrome, or MDS, a bone marrow failure state that may convert to leukemia.

In addition to his work at Dana-Farber, Dr. Stone serves as Chair of the Subspecialty Board on Medical Oncology of the American Board of Internal Medicine, Chair of the Medical Board of the International Aplastic Anemia and MDS Foundation, Co-Chair of the National Cancer Institute’s Sub-committee H grant review panel for cancer cooperative trial groups, and Vice-Chair of the Leukemia Core Committee for the national cooperative trials group Cancer and Leukemia Group B.

Dr. Stone earned his medical degree from Harvard Medical School. He completed his internal medicine residency training at Brigham and Women’s Hospital, and his hematology-oncology fellowship at Dana-Farber.

Joan Von Feldt, MD

Dr. Von Feldt is Professor of Medicine in the Division of Rheumatology at the University of Pennsylvania School of Medicine and Associate Chief of Staff-Education at the Philadelphia VA Medical Center. She is a clinician with recognized regional and national expertise in Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis and has an active clinical research focus. Her current research is on premature atherosclerotic disease in SLE and Health Literacy in the Rheumatic Diseases.

Dr. Von Feldt was recently elected to the American Board of Internal Medicine Board of Directors and serves as Chair of the Subspecialty Board on Rheumatology. Currently, she is on the Board of Directors of the American of Rheumatology and is Treasurer of Pan American League of Associations of Rheumatology.

She has devoted significant time to educational activities at the University of Pennsylvania as a member of the Curriculum Committee. She is currently course director of the Differential Diagnosis course for pre-clerkship students. In addition, she has also served as the Rheumatology Specialty Liaison for the Internal Medicine Residency program and Program Director for the Rheumatology training program.

Dr. Von Feldt has published over 60 peer-reviewed articles, editorials and book chapters. She is Associate Editor for Journal of Clinical Rheumatology and serves as an ad hoc reviewer for numerous other publications.

She received her medical degree from the Medical College of Pennsylvania and completed her fellowship in rheumatology at the University of Pennsylvania. Additionally, she holds a master’s degree in education.

Keith Randall Young Jr., MD

Dr. Young, a board certified internist, pulmonologist and allergist/immunologist, is the Chairman of the Division of Pulmonary and Critical Care Medicine at the Albert Einstein Medical Center in Philadelphia, PA. Prior to assuming that position in the Summer of 2011, he was a faculty member at the University of Alabama at Birmingham, where he directed the Division of Pulmonary/Allergy/Critical Care Medicine for 15 years and also served as the Director of the Adult Cystic Fibrosis Program, the Co-Principal Investigator of UAB’s site in the Cystic Fibrosis Foundation’s Therapeutics Development Network, and the Medical Director of VIVA Health, a health insurance company that is part of the UAB Health System.

His national positions have included serving as President of the Association of Specialty Professors, President of the Association of Pulmonary and Critical Care Medicine Program Directors and a member of the Board of Regents of the American College of Chest Physicians.

Dr. Young is a graduate of the Massachusetts Institute of Technology and Jefferson Medical College. He completed an internship and residency in Internal Medicine at the Yale-New Haven Hospital, where he remained for a chief residency in Internal Medicine and a fellowship in Pulmonary and Critical Care Medicine. Prior to joining the UAB faculty, he served a medical staff fellowship in the Laboratory of Immunoregulation at the National Institute of Allergy and Infectious Diseases. He serves as Chair of the ABIM Subspecialty Board on Pulmonary Disease.